In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004

od Hecht, David W., Galang, Minerva A., Sambol, Susan P., Osmolski, James R., Johnson, Stuart, Gerding, Dale N.
Izdano 2007

Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027

od Wieczorkiewicz, Jeffrey T., Lopansri, Bert K., Cheknis, Adam, Osmolski, James R., Hecht, David W., Gerding, Dale N., Johnson, Stuart
Izdano u Antimicrob Agents Chemother (2015)

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients

od Kociolek, Larry K., Gerding, Dale N., Osmolski, James R., Patel, Sameer J., Snydman, David R., McDermott, Laura A., Hecht, David W.
Izdano u Antimicrob Agents Chemother (2016)

Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile

od Miesel, Lynn, Hecht, David W., Osmolski, James R., Gerding, Dale, Flattery, Amy, Li, Fangbiao, Lan, Jing, Lipari, Philip, Polishook, Jon D., Liang, Lianzhu, Liu, Jenny, Olsen, David B., Singh, Sheo B.
Izdano 2014